|
1
|
Shelke AR and Mohile SG: Treating prostate
cancer in elderly men: How does aging affect the outcome? Curr
Treat Options Oncol. 12:263–275. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Crawford ED: Understanding the
epidemiology, natural history, and key pathways involved in
prostate cancer. Urology. 73(5 Suppl): S4–S10. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bosland MC: The role of steroid hormones
in prostate carcinogenesis. J Natl Cancer Inst Monogr. 1–66.
2000.PubMed/NCBI
|
|
4
|
Crawford ED: Prostate cancer.
Introduction. Urology. 62(6 Suppl 1): S1–S2. 2003. View Article : Google Scholar
|
|
5
|
Grönberg H: Prostate cancer epidemiology.
Lancet. 361:859–864. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Crawford ED: Epidemiology of prostate
cancer. Urology. 62(6 Suppl 1): S3–S12. 2003. View Article : Google Scholar
|
|
7
|
Whittemore AS, Kolonel LN, Wu AH, John EM,
Gallagher RP, Howe GR, Burch JD, Hankin J, Dreon DM, West DW, et
al: Prostate cancer in relation to diet, physical activity, and
body size in blacks, whites, and Asians in the United States and
Canada. J Natl Cancer Inst. 87:652–661. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gravdal K, Halvorsen OJ, Haukaas SA and
Akslen LA: A switch from E-cadherin to N-cadherin expression
indicates epithelial to mesenchymal transition and is of strong and
independent importance for the progress of prostate cancer. Clin
Cancer Res. 13:7003–7011. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tomita K, van Bokhoven A, van Leenders GJ,
Ruijter ET, Jansen CF, Bussemakers MJ and Schalken JA: Cadherin
switching in human prostate cancer progression. Cancer Res.
60:3650–3654. 2000.PubMed/NCBI
|
|
11
|
Shiozawa Y, Pedersen EA, Havens AM, Jung
Y, Mishra A, Joseph J, Kim JK, Patel LR, Ying C, Ziegler AM, et al:
Human prostate cancer metastases target the hematopoietic stem cell
niche to establish footholds in mouse bone marrow. J Clin Invest.
121:1298–1312. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Steeg PS: Cancer biology: Emissaries set
up new sites. Nature. 438:750–751. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Alexander NR, Tran NL, Rekapally H,
Summers CE, Glackin C and Heimark RL: N-cadherin gene expression in
prostate carcinoma is modulated by integrin-dependent nuclear
translocation of Twist1. Cancer Res. 66:3365–3369. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Collins AT, Berry PA, Hyde C, Stower MJ
and Maitland NJ: Prospective identification of tumorigenic prostate
cancer stem cells. Cancer Res. 65:10946–10951. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kong D, Banerjee S, Ahmad A, Li Y, Wang Z,
Sethi S and Sarkar FH: Epithelial to mesenchymal transition is
mechanistically linked with stem cell signatures in prostate cancer
cells. PLoS One. 5:e124452010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Maitland NJ and Collins A: A tumour stem
cell hypothesis for the origins of prostate cancer. BJU Int.
96:1219–1223. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pavese JM and Bergan RC: Circulating tumor
cells exhibit a biologically aggressive cancer phenotype
accompanied by selective resistance to chemotherapy. Cancer Lett.
352:179–186. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sak K: Site-specific anticancer effects of
dietary flavonoid quercetin. Nutr Cancer. 66:177–193. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sak K: Cytotoxicity of dietary flavonoids
on different human cancer types. Pharmacogn Rev. 8:122–146. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gupta S, Afaq F and Mukhtar H: Selective
growth-inhibitory, cell-cycle deregulatory and apoptotic response
of tangeretin in normal versus human prostate carcinoma cells.
Biochem Biophys Res Commun. 287:914–920. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pan MH, Chen WJ, Lin-Shiau SY, Ho CT and
Lin JK: Tangeretin induces cell-cycle G1 arrest through inhibiting
cyclin-dependent kinases 2 and 4 activities as well as elevating
Cdk inhibitors p21 and p27 in human colorectal carcinoma cells.
Carcinogenesis. 23:1677–1684. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
el SA Arafa, Zhu Q, Barakat BM, Wani G,
Zhao Q, El-Mahdy MA and Wani AA: Tangeretin sensitizes
cisplatin-resistant human ovarian cancer cells through
downregulation of phosphoinositide 3-kinase/Akt signaling pathway.
Cancer Res. 69:8910–8917. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dong Y, Cao A, Shi J, Yin P, Wang L, Ji G,
Xie J and Wu D: Tangeretin, a citrus polymethoxyflavonoid, induces
apoptosis of human gastric cancer AGS cells through extrinsic and
intrinsic signaling pathways. Oncol Rep. 31:1788–1794. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lakshmi A and Subramanian S:
Chemotherapeutic effect of tangeretin, a polymethoxylated flavone
studied in 7, 12-dimethylbenz(a)anthracene induced mammary
carcinoma in experimental rats. Biochimie. 99:96–109. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Periyasamy K, Baskaran K, Ilakkia A,
Vanitha K, Selvaraj S and Sakthisekaran D: Antitumor efficacy of
tangeretin by targeting the oxidative stress mediated on
7,12-dimethylbenz(a) anthracene-induced proliferative breast cancer
in Sprague-Dawley rats. Cancer Chemother Pharmacol. 75:263–272.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Das A, Bhattacharya A, Chakrabarty S,
Ganguli A and Chakrabarti G: Smokeless tobacco extract
(STE)-induced toxicity in mammalian cells is mediated by the
disruption of cellular microtubule network: A key mechanism of
cytotoxicity. PLoS One. 8:e682242013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Balint K, Xiao M, Pinnix CC, Soma A, Veres
I, Juhasz I, Brown EJ, Capobianco AJ, Herlyn M and Liu ZJ:
Activation of Notch1 signaling is required for
beta-catenin-mediated human primary melanoma progression. J Clin
Invest. 115:3166–3176. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Di Cello F, Flowers VL, Li H,
Vecchio-Pagán B, Gordon B, Harbom K, Shin J, Beaty R, Wang W,
Brayton C, et al: Cigarette smoke induces epithelial to mesenchymal
transition and increases the metastatic ability of breast cancer
cells. Mol Cancer. 12:902013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tanno B, Sesti F, Cesi V, Bossi G,
Ferrari-Amorotti G, Bussolari R, Tirindelli D, Calabretta B and
Raschellà G: Expression of Slug is regulated by c-Myb and is
required for invasion and bone marrow homing of cancer cells of
different origin. J Biol Chem. 285:29434–29445. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chang L, Graham PH, Hao J, Ni J, Bucci J,
Cozzi PJ, Kearsley JH and Li Y: Acquisition of
epithelial-mesenchymal transition and cancer stem cell phenotypes
is associated with activation of the PI3K/Akt/mTOR pathway in
prostate cancer radioresistance. Cell Death Dis. 4:e8752013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ni J, Cozzi P, Hao J, Beretov J, Chang L,
Duan W, Shigdar S, Delprado W, Graham P, Bucci J, et al: Epithelial
cell adhesion molecule (EpCAM) is associated with prostate cancer
metastasis and chemo/radioresistance via the PI3K/Akt/mTOR
signaling pathway. Int J Biochem Cell Biol. 45:2736–2748. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Taylor BS, Schultz N, Hieronymus H,
Gopalan A, Xiao Y, Carver BS, Arora VK, Kaushik P, Cerami E, Reva
B, et al: Integrative genomic profiling of human prostate cancer.
Cancer Cell. 18:11–22. 2010. View Article : Google Scholar : PubMed/NCBI
|
